Powerful solutions for Pre Launch/Early-Stage Assets
- Comprehensive Literature searches for epi, market growth projections
- Sizing Treatment Flows and Market Shares analysis using Big Data/ Claims/EMR/EHR/Lab etc.
- Dynamic Patient Journey quantification and visualization
ML solution predicted with 76% accuracy 3k new patients with a high likelihood of being prescribed the target brand, translating to $480M in potential revenue.
Brand Opportunity Assessments
- Patient based Forecast Model to size opportunity and build scenarios for different share, access, promotional & market entry/competitor event options
- Leverage Points Workshops to size & prioritize brand opportunities
- Strategic Consulting & Analysis Support
Harness the predictive power of AI ML & NLP to find un-diagnosed emerging patients.
COVID-19’s impact on forecasted sales was not expected. This POV demonstrates a new framework and solution for Monthly…
- Assessment of Access environment in given therapy area
- Payer Influence / Payer Mix Analyses
- Time to Reimbursement for available therapies – Remit/PlanTrak and other data assets
- Treatment shares by Payer /Plan using claims data
The Machine Learning Solution predicted likely share and rebate scenarios at a Plan level to enable optimization.
Clinical Trial Accelerator
- IZE Trial Optimizer offering
- Proactive field-based triggers to find appropriate patients
- Proven to accelerate recruitment and time to market
- Particularly relevant for difficult to recruit Rare Disease/ niche Indications
- AI/ML predictive modelling, NLP analytics for translating medical notes
Harness the predictive power of AI ML & NLP to expedite clinical trial enrollment.